norethindrone has been researched along with 46, XY Gonadal Dysgenesis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Athanasopoulos, N; Creatsas, G; Deligeoroglou, E; Economou, E; Lambrinoudaki, I; Mastorakos, G; Papamichael, C; Rizos, D; Stamatelopoulos, K; Tsimaris, P | 1 |
1 other study(ies) available for norethindrone and 46, XY Gonadal Dysgenesis
Article | Year |
---|---|
The effect of hormone therapy on biochemical and ultrasound parameters associated with atherosclerosis in 46,XY DSD individuals with female phenotype.
Topics: Adolescent; Adult; Androgen-Insensitivity Syndrome; Atherosclerosis; Drug Combinations; Endothelium, Vascular; Estradiol; Estrogens; Female; Gonadal Dysgenesis, 46,XY; Humans; Male; Norethindrone; Norethindrone Acetate; Progestins; Treatment Outcome; Ultrasonography; Young Adult | 2014 |